Germline mutations in Ras pathway components are associated with a large class of human developmental abnormalities, known as RASopathies, that are characterized by a range of structural and functional phenotypes, including cardiac defects and neurocognitive delays 1,2 . Although it is generally believed that RASopathies are caused by altered levels of pathway activation, the signaling changes in developing tissues remain largely unknown 3,4 . We used assays with spatiotemporal resolution in Drosophila melanogaster (fruit fly) and Danio rerio (zebrafish) to quantify signaling changes caused by mutations in MAP2K1 (encoding MEK), a core component of the Ras pathway that is mutated in both RASopathies and cancers in humans 5, 6 . Surprisingly, we discovered that intrinsically active MEK variants can both increase and reduce the levels of pathway activation in vivo. The sign of the effect depends on cellular context, implying that some of the emerging phenotypes in RASopathies may be caused by increased, as well as attenuated, levels of Ras signaling.
Germline mutations in Ras pathway components are associated with a large class of human developmental abnormalities, known as RASopathies, that are characterized by a range of structural and functional phenotypes, including cardiac defects and neurocognitive delays 1,2 . Although it is generally believed that RASopathies are caused by altered levels of pathway activation, the signaling changes in developing tissues remain largely unknown 3, 4 . We used assays with spatiotemporal resolution in Drosophila melanogaster (fruit fly) and Danio rerio (zebrafish) to quantify signaling changes caused by mutations in MAP2K1 (encoding MEK), a core component of the Ras pathway that is mutated in both RASopathies and cancers in humans 5, 6 . Surprisingly, we discovered that intrinsically active MEK variants can both increase and reduce the levels of pathway activation in vivo. The sign of the effect depends on cellular context, implying that some of the emerging phenotypes in RASopathies may be caused by increased, as well as attenuated, levels of Ras signaling.
MEK (also known as MAP2K1 or MEK1) is a ubiquitously expressed kinase that remains inactive until it is phosphorylated in response to extracellular signals, such as locally secreted ligands of receptor tyrosine kinases (RTKs) 7 . Reflecting the patterns of RTK activation, the activity of MEK is regulated in both space and time, providing tight control of the activation of its direct substrate, extracellularsignal-regulated kinase (ERK). Studies with cultured cells suggest that the MEK variants identified in individuals with RASopathies and cancers are active even without upstream signals 5, 6 . To examine this possibility more directly, we reconstituted a biochemical system comprising purified rat ERK2 (also known as MAPK1), human MEK variants, and ATP (Fig. 1a,b) . We found that four of the five disease-related variants examined cause strong ERK2 phosphorylation (dpERK) (Fig. 1c,  Supplementary Fig. 1 , and Supplementary Tables 1 and 2 ). This result establishes the intrinsic activity of the mutants and suggests that some of their effects in embryos may derive from ectopic pathway activation. At the same time, the corresponding mutations may affect cellular responses to endogenous inductive signals, resulting in altered kinetics of ERK activation. Thus, the biological effects of activating mutations are likely to reflect a combination of ectopic pathway activation and altered responses to endogenous cues. l e T T e r S
Divergent effects of intrinsically active MEK variants on developmental Ras signaling
The early Drosophila embryo provides a powerful system for exploring both of these scenarios. We focused on the first wave of ERK signaling in the early blastoderm, when the embryo has a particularly simple anatomy with a uniform field of nuclei arranged under a common plasma membrane. At this stage, ERK activation is triggered by a locally produced ligand (Trunk) via a uniformly expressed RTK (Torso), resulting in a pattern of ERK activation where activity is localized to the embryonic poles and is negligible in the middle of the embryo (Fig. 2a) 8, 9 . The fly embryo can thus be used to simultaneously assess the effects of activating mutations on endogenous signaling (poles) and the ability of these mutations to trigger ectopic pathway activation (middle of the embryo).
We used the Gal4-UAS system to uniformly express the intrinsically active MEK variants (Supplementary Fig. 2 ) in the early embryo from a maternal pool of RNA and quantified their effects on ERK phosphorylation. Consistent with their ability to phosphorylate ERK in the absence of upstream signals, these variants induced a significant Remarkably, ERK phosphorylation was strongly reduced at the embryonic poles, to ~50% of wild-type levels ( Fig. 2b-i and Supplementary Fig. 4 ). Thus, intrinsically active MEK variants have opposing effects on developmental ERK activation: they induce ectopic pathway activation and, surprisingly, strongly attenuate response to endogenous signals. Notably, both of these effects had major consequences for the subsequent stages of tissue patterning and morphogenesis. In particular, ectopic ERK activation in the central region of the embryo resulted in dramatic alterations in expression of gap genes, such as tailless (tll) ( Fig. 3a and Supplementary Figs. 6-9), which have a critical role in regulating segmentation along the anteroposterior axis 10 . Consequently, the larval cuticles produced by embryos expressing active MEK variants had a range of patterning defects, from fused segments to complete loss of the segmented pattern (Fig. 3b) . These defects in gene expression and morphogenesis are fully consistent with the previously reported effects of other gain-of-function mutations in the Ras pathway [11] [12] [13] . Note that these strong defects are triggered by ectopic levels of ERK activation that are significantly lower than the maximal levels of endogenous pathway activation at the poles ( Fig. 2c-e) .
Given the strong reduction in ERK activation at the poles observed with expression of the variants, we asked whether these changes phenocopy the defects observed in response to genetic perturbations that either abolish or strongly attenuate Ras signaling. Some of the canonical defects associated with loss of ERK activation in the early embryo correspond to loss of the most anterior head structures 11, 14 and a 'pole-hole' phenotype 14, 15 , in which some of the nuclei at the posterior pole are displaced from the plasma membrane. These defects can be induced by loss of the Torso receptor 11, 16 , by loss of Raf 17 , which activates and phosphorylates MEK, or by strong RNA interference (RNAi)-mediated knockdown of MEK itself (Fig. 3c,d and Supplementary Fig. 10 ). Remarkably, both loss of head structures ( Fig. 3c) and a pole-hole phenotype (Fig. 3d) were induced by the constitutively active MEK variants. Hence, morphological defects resulting from activating mutations can have very different origins in different locations of the embryo. Some defects, including disruption of the segmented pattern, are caused by ectopic signaling, whereas others, such as the pole-hole phenotype, reflect attenuated response to patterning signals.
What is the basis of these divergent effects of activating mutations? ERK activation can induce expression of inhibitors that can negatively regulate signal transduction at multiple points along the pathway, establishing negative feedback 18, 19 . As a consequence, precocious pathway stimulation induced by intrinsically active mutations can desensitize the pathway to future rounds of signaling. To illustrate this point, consider a mathematical model (Fig. 4 and Supplementary  Fig. 11a,b) in which the pathway is stimulated by a sum of two inputs. The first input is localized in space and time (u(x,t)), mimicking the effects of normal inductive signals. The second input is uniform in space and time (u 0 ), mimicking the effects of intrinsically active mutants. Signaling levels (S) decay with first-order kinetics and trigger expression of an inhibitor (I) that attenuates the combined effect of the two inputs (Supplementary Table 3) .
Motivated by the localized activation of the Torso pathway, the inductive input is modeled as a pulse in both space and time. In the absence of activating mutations, signaling levels are negligible in cells Differential equations governing the model; here u 0 and u(x,t) are ligand-independent and ligand-dependent inputs, respectively, S is the signal, I is the inhibitor; k is the rate constant of signal degradation, and a is the strength of feedback. Additional modeling details and parameter values are provided in Supplementary Table 3 . Heat maps of the ratio of dpERK intensity in wild-type embryos to that in embryos expressing Phe53Ser MEK, generated by the model (c) and obtained from data (d). In both cases, the ratio changes from >1 (at the pole) to <1 (in the middle of the embryo).
(e) Heat map of the ratio of dpERK intensity in wild-type embryos (n = 55) to that in embryos carrying a constitutively active mutation in torso mapping to Asp4021 (n = 51). Individual heat maps for wild-type embryos and embryos expressing mutants are shown in Supplementary  Figure 13 . (f) Pairwise comparison of dpERK levels in wild-type embryos (n = 16) and embryos expressing PTTH (n = 28). Error bars, s.e.m.
l e T T e r S that do not receive the inductive signal, as seen in spatiotemporal reconstruction of ERK activation ( Fig. 5a and Supplementary  Fig. 12 ). The situation is different when mutations are present, as the pathway is stimulated throughout the system, even before the inductive signals arrive. In this case, inductive inputs act on the background with a nonzero level of inhibitor(s), induced by precocious pathway stimulation resulting from the activating mutations. As a result, response to endogenous cues is strongly attenuated (Fig. 5b) . According to the model, the sign of the effect of activating mutations-illustrated by the ratio of signal for wild-type embryos to that for embryos expressing mutant MEK-changes across the system, from negative in cells that receive endogenous signals to positive in the rest of the tissue ( Fig. 5c and Supplementary Fig. 11c,d ). The effect is dynamic and reflects spatially uniform pathway activation that precedes arrival of inductive cues. This is fully consistent with the reconstruction of such a ratio from staged embryos (Fig. 5d) .
In this model, the feedback inhibitor senses the constitutive activity, accumulates over time, and desensitizes cells, which receive the endogenous signals at later times. Therefore, the feedback model predicts that the same effect is not limited to MEK-activating mutations and can be induced by any other means of spatially uniform and precocious pathway activation. To test this prediction, we examined ERK activation in embryos with two types of genetic perturbations. First, we used embryos carrying a strong activating mutation in torso (Tor D4021 ) 13 . Second, we used embryos with spatially uniform expression of PTTH, another ligand of Torso 20 . Consistent with the model, in both cases we observed ectopic ERK activation in the middle of the embryo and strong reduction of ERK activity at the poles (Fig. 5e,f and Supplementary Fig. 13 ). To summarize, the divergent effects of activating mutations are not limited to MEK and can be induced by activating perturbations in other components of the RTK pathway. Indeed, a few studies have associated loss-of-function phenotypes with activating mutations in the Ras pathway 21, 22 . Our results suggest that such phenotypes may result from attenuated signaling levels. It is likely that multiple negative regulators work together to reduce ERK activity at the poles of the embryo. In the future, these regulators can be identified using a combination of candidate gene and unbiased approaches.
We expect that the divergent effects of activating mutations identified by our experiments in Drosophila represent a general property of developmental signaling by locally activated RTKs. As a first step toward testing this hypothesis, we focused on ERK activation in the zebrafish embryo during epiboly. During this stage, ERK signaling is triggered by locally produced fibroblast growth factor (FGF) ligand, via uniformly expressed FGF receptor (FGFR), resulting in a pattern of ERK activation that is localized to the blastoderm margin and negligible in the animal cap 23 . We used mRNA injection to induce mosaic expression of human MEK variants in the early embryo, facilitating quantitative spatial comparisons of ERK activation (Fig. 6a) . In the animal cap, which does not receive endogenous Ras signaling in wild-type embryos, MEK variants caused ectopic ERK activation (Fig. 6a-c and Supplementary Figs. 14a, 15, and 16a,b) . In the blastoderm margin, however, we observed attenuated ERK activation, consistent with our observations in Drosophila (Fig. 6a,d,e and Supplementary Figs. 14-16) . Furthermore, while ectopic signaling resulted in an oval embryo shape, a gain-of-function defect, In the animal cap, wild-type MEK does not affect dpERK levels (n = 13) (b), whereas the MEK variants Phe53Leu (n = 10) (c) and Gly128Val (n = 8) ( Supplementary Fig. 14a ) result in increased dpERK levels. (d,e) In the blastoderm margin, wild-type MEK does not affect dpERK levels (n = 15) (d), whereas the MEK variants Phe53Leu (n = 11) (e) and Gly128Val (n = 8) ( Supplementary Fig. 14) result in decreased dpERK levels. In b-e, P values were obtained by Student's t-test (two-sided, paired). Error bars, s.e.m. (f,g) Wild-type MEK does not affect cilia length in Kupffer's vesicle, which was measured at the 14-somite stage (16 hours post-fertilization (h.p.f.)) (uninjected: n = 6 embryos, 211 cilia; wild type injected: n =l e T T e r S reduced signaling at the blastoderm margin resulted in shorter cilia in Kupffer's vesicle (Fig. 6f-i) , a phenotype associated with loss of FGF signaling 24, 25 . Thus, similar to observations in Drosophila, MEKactivating mutations cause ectopic signaling and attenuate response to endogenous inputs to RTKs. To summarize, our results underscore the complexity of signaling changes that can be induced by activating mutations in components of the Ras pathway. We found that the magnitude and even the sign of the effect may vary in vivo. Therefore, the structural and morphological defects observed in individuals with these mutations may have different origins: some defects may result from ectopic signaling, whereas other defects may result from attenuated sensitivity to inductive cues. In the future, this possibility should be tested in mammalian models of RASopathies and should be kept in mind when considering proposed pharmacological treatments of RASopathies using existing inhibitors of Ras signaling. In light of our data, predicting the results of these treatments is nontrivial. Because some aberrant phenotypes may be caused by decrease or loss of ERK signaling, uniform inhibition of ERK signaling may correct only some defects and can potentially worsen others. Going beyond the RAS pathway, it will be important to test whether divergent effects on pathway activation can be caused by activating mutations in other signal transduction pathways [26] [27] [28] .
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Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
oNLINE METhodS
Plasmid construction, protein expression, and protein purification for in vitro reactions. pET28 plasmid encoding N-terminally His 6 -tagged human (MAP2K1) was a gift from E. Goldsmith (UT Southwestern). Plasmids encoding N-terminally tagged MEK mutants were constructed by overlap PCR of the 5′ and 3′ ends of the gene fragment produced by standard PCR using primers containing the desired mutation. The mutant MAP2K1 inserts and pET28 plasmid were digested using the same restriction enzymes used to clone wild-type MAP2K1 into pET28 (BamHI and XhoI), ligated, and transformed into Escherichia coli for plasmid amplification and protein expression. The N-terminally His 6 -tagged rat ERK2 expression construct was produced by standard PCR amplification of the MAPK1 sequence, digestion of the gene and pQE80 plasmid by BamHI and HindIII, ligation, and transformation into E. coli for plasmid amplification and protein expression.
For expression of MEK variants, pET28 plasmids encoding MEK variants were transformed into E. coli BL21 (DE3) competent cells. Overnight cultures were subcultured into 1.5 l LB medium supplemented with 35 µg/ml kanamycin to a starting OD 600 of 0.02. Cultures were grown at 37 °C with agitation at 250 r.p.m. until they reached OD 600 of 0.9-1.1. Protein expression was induced by the addition of isopropyl-β-d-1-thiogalactopyranoside (IPTG) to a final concentration of 0.5 mM, and cultures were grown for 6 h at 25 °C with agitation at 200 r.p.m. Cells were collected by centrifugation, and cell pellets were stored at −20 °C.
For expression of ERK2, pQE80 plasmid encoding tagged ERK2 was transformed into E. coli BL21 (DE3) competent cells. Overnight cultures were subcultured into 1 l LB medium supplemented with 100 µg/ml ampicillin to a starting OD 600 of 0.02, and cultures were grown at 37 °C with agitation at 250 r.p.m. until they reached OD 600 of 1.0. Protein expression was induced with 1 mM IPTG, and cultures were grown at 22 °C for 6 h with agitation at 250 r.p.m. Bacterial cell pellets were collected by centrifugation and stored at −20 °C.
For all protein purifications, cell pellets were resuspended in 40 ml of 10 mM imidazole, 300 mM NaCl, 50 mM NaH 2 PO 4 , pH 8, and lysed by treatment with lysozyme and sonication on ice. Cell debris was removed by centrifugation, and the supernatant was sterile filtered. All proteins were purified from clarified lysate using Ni-NTA agarose resin (Qiagen) following the manufacturer's recommendations. ERK2 underwent buffer exchange into 50 mM HEPES, 100 mM NaCl, 20 mM MgCl 2 , 10% glycerol, pH 7.4, using PD-10 desalting columns (Bio-Rad). MEK was further purified by gel filtration chromatography using a Superdex 75 16/600 column (GE Healthcare Life Sciences) equilibrated with 50 mM HEPES, 100 mM NaCl, 20 mM MgCl 2 , 10% glycerol, pH 7.4. Aliquots of 5-50 µl were snap frozen in liquid nitrogen and stored at −80 °C until use in phosphorylation reactions.
In vitro phosphorylation reactions. MEK-ERK phosphorylation reactions were carried out in 50 mM HEPES, 100 mM NaCl, 20 mM MgCl 2 , and 1 mM ATP (pH 7.4). For MEK:ERK ratios of 1:5 and 1:10, 2 µM MEK was reacted with 10 µM ERK2 and 20 µM ERK2, respectively. Reactions were initiated by the addition of MEK to a master mix containing ERK and phosphorylation buffer and were run for 90 min at 30 °C. Reaction aliquots were diluted fourfold in 8 M urea to terminate the reaction. Four separate reactions were run for the data presented in Supplementary Table 1. Immunoblotting. 4× SDS loading buffer was added to reaction aliquots, and immunoblotting was performed using standard techniques on LF PVDF membrane. Primary antibodies to MEK (1:4,000 dilution; Cell Signaling Technology, 8727), dpERK (1:4,000 dilution; Cell Signaling Technology, 4370), and ERK (1:4,000 dilution; Cell Signaling Technology, 4695) were used to track the presence of total MEK, dpERK, and ERK, respectively. Alexa Fluor conjugates (1:2,000 dilution; Invitrogen) were used as secondary antibodies, and membranes were imaged using the Bio-Rad ChemiDoc MP Imaging System. Fly stocks. Five mutations were introduced into cDNA for Dsor1 (encoding MEK; a gift from A. Veraksa (University of Massachusetts, Boston)) using site-directed mutagenesis with Phusion enzyme (New England BioLabs) and verified by sequencing. Wild-type and mutant versions were cloned into the transformation vector pTIGER 29 between the NheI and XbaI restriction sites.
These constructs were integrated into the second chromosome using the φC31-based integration system 30 at the attP site estimated to be at 25C6. UAS-MEK RNAi (Bloomington stock 36099), Histone-GFP, tor D4021 /+ (a gift from X. Jimenez (IBMB)), and UAS-PTTH (a gift from C. Warr (Monash University)) were also used in the experiments. MTD-Gal4 (Bloomington stock 31777), P(matα-GAL-VP16)mat67; P(matα-GAL-VP16)mat15 (ref. 31) , and nos-Gal4 (Bloomington stock 32563) were used to drive expression in the early embryo.
Zebrafish injections. In pCS2(+) (Invitrogen), the EcoRI site was changed to EcoRV, and human MAP2K1 (a gift from R. Seger (Weizmann Institute)) was subsequently cloned between the BamHI and EcoRV restriction sites, while mCherry sequence was cloned between the EcoRV and XhoI restriction sites. The set of two mutations was introduced into this construct with site-directed mutagenesis using Phusion enzyme (New England BioLabs). The plasmids were then linearized using NotI, and synthetic capped mRNA was synthesized using the SP6 RNA polymerase mMessage mMachine kit (Ambion) and purified using TRIzol reagent. Microinjection with 500 pl of the RNA mixture at a concentration of ~110 pg/nl (55 pg) was performed using the PV280 Pneumatic PicoPump (World Precision Instruments). Embryos were acquired by pair mating of PWT fish. Established zebrafish protocols were adhered to in accordance with the Princeton University Institutional Animal Care and Use Committee.
Cuticle preparation. Embryos were dechorionated after being aged for more than 24 h. Dechorionated embryos were shaken in methanol and heptane (1:1) and incubated overnight in medium containing lactic acid and Hoyer's medium (1:1) at 65 °C. Embryos were imaged on a Nikon Eclipse Ni.
Immunostaining and FISH. Drosophila. Antibody staining and FISH protocols were performed as described elsewhere 32 . Rabbit antibody to dpERK (1:100 dilution; Cell Signaling Technology, 4370), rabbit antibody to ERK (1:100 dilution; Cell Signaling Technology, 4695), rabbit antibody to MEK (1:100 dilution; Cell Signaling Technology, 8727), sheep antibody to GFP (1:1,000 dilution; Bio-Rad, 4745-1051), rabbit antibody to GFP (1:1,000 dilution; Life Technologies, A11122), sheep antibody to digoxigenin (DIG) (1:125 dilution; Roche, 11333089001), and mouse antibody to biotin (1:125 dilution; Jackson Immunoresearch, 200-002-211) were used as primary antibodies. DAPI (1:10,000 dilution; Molecular Probes, D1306) was used to stain nuclei, and Alexa Fluor conjugates (1:500 dilution; Invitrogen) were used as secondary antibodies.
Zebrafish. Rabbit antibody to dpERK (1:100 dilution; Cell Signaling Technology, 4370) and rat antibody to mCherry (1:1,000 dilution; Life Technologies, M11217) were used as primary antibodies. The zebrafish immunofluorescence protocol was as follows: embryos were washed twice in 1× PBST (1× PBS containing 0.1% Tween-20), transitioned to 100% methanol, and stored at −20 °C overnight. Embryos were transitioned into PBST by performing 5-min washes in 75% methanol:25% 1× PBST, 50% methanol:50% 1× PBST, 25% methanol:75% 1× PBST, and 1× PBST. Embryos were washed three more times in 1× PBST with 5 min per wash. Embryos were blocked for 2 h in 1× PBDT (1× PBST containing 1% DMSO) supplemented with 10% normal sheep serum (NSS). Embryos were then incubated overnight in 1× PBDT containing 10% NSS and the appropriate dilution of the primary antibody at 4 °C. Embryos were quickly washed in 1× PBDT containing 1% NSS and 0.1 M NaCl followed by five more 30-min washes. Embryos were then washed for 30 min in 1× PBDT containing 1% NSS (1× PBDT-NSS), followed by overnight incubation in 1× PBDT-NSS containing a 1:400 dilution of the appropriate Alexa Fluor-conjugated secondary antibody at 4 °C. Embryos were then washed in 1× PBDT containing 1% NSS and 0.1 M NaCl for 1 min followed by five more 30-min washes. The final wash was in 1× PBDT for 30 min. For epiboly-stage embryos, all steps were performed in glass specimen vials, as opposed to microfuge tubes, as this was found to better preserve embryo structure. In addition, transitioning to and from methanol was not performed for epiboly-stage embryos.
Microscopy and image processing. Drosophila. Fluorescent imaging was performed on a Nikon A1-RS scanning confocal microscope with a 20× objective.
For pairwise comparisons of wild-type and mutant backgrounds, embryos were collected, stained, and imaged together under the same experimental conditions. Broken embryos, embryos with intact vitelline membrane, and embryos undergoing mitosis were excluded from the analysis.
Heat map reconstruction. Pre-cellularization embryos were timed on the basis of surface nuclear density as determined by DAPI staining, using a previously described image processing toolbox 33 . Nuclear cycle 14 embryos were timed on the basis of membrane invagination progression during cellularization, as described previously 32 . Membrane length in the fixed embryos was measured from phase-contrast images. Using a combination of these two independent time markers, we obtained ten pooled time-stamped fluorescent intensities for four different positions (x i ) from the anterior pole (x = 0) to the middle (x = 0.5) of the embryo. Fluorescent intensity (FI) was normalized using the formula where FL min and FL max correspond to global minimum and maximum intensity, respectively, from the wild-type and respective mutant backgrounds. Normalized space-time fluorescent intensities were entered in MATLAB (R2015b, Mathworks). Matrix smoothing was performed using the MATLAB command 'fit' with the 'loess' smoothing method and a span of 1 to generate the heat maps in Figure 5 . To obtain heat maps for ratio plots, smoothened heat maps for the wild-type and mutant backgrounds were divided against each other. For more details, see Supplementary Figure 12 .
Spatial profiles. Nuclear cycle 14 embryos were staged using membrane length as the independent time marker such that all embryos were within ~15 min of each other.
Cuticle imaging was performed with a Nikon Eclipse Ni. Calculation of the posterior tailless domain was performed using a previously described protocol 34 .
Zebrafish. Fluorescent imaging was performed on a Nikon A1-RS scanning confocal microscope with a 10× objective. For pairwise comparisons of uninjected and injected embryos, embryos were fixed, stained, and imaged together under the same experimental conditions. Broken embryos were excluded from the analysis.
Mathematical model. The primary purpose of formulating the model was to qualitatively capture the observed divergent effects of constitutively active mutations on developmental signaling. The model includes two types of inputs: u(x,t), which is a ligand-dependent pulse that is regulated in space and time and is the same for wild-type and mutant embryos, and u 0 , which is invariant in space and time and represents the constitutive activity of the pathway. We relied on the experimentally reconstructed heat map of ERK activation in wild type to infer the timescale and length scale for u(x,t) (Supplementary Table 3 ). Notably, no parameter fitting was performed. These two inputs result in a signal (S) that decays with a rate constant (k) and generates negative feedback (I) with a feedback strength (a). The negative feedback could be transcriptional 35, 36 and/or post-translational [37] [38] [39] [40] [41] [42] [43] [44] , but our model does not discriminate between different types of pathway inhibition. Signaling dynamics in space and time are governed by two coupled differential equations Differential equations were solved with the zero-initial conditions for both variables (S and I). Details on the model parameters and functions are presented in Supplementary Figure 11 and Supplementary Table 3 .
Cilia measurements. Zebrafish embryos were fixed overnight at 14 h.p.f.
(ten-somite stage) in 4% paraformaldehyde at 4 °C, and the immunofluorescence protocol, as described earlier, was performed with mouse antibody to acetylated α-tubulin (1:400 dilution; Sigma-Aldrich, T6793). Embryos were flat-mounted according to a previously published protocol 45 . The yolk was first removed from the embryos, and they were then flattened in Aqua Poly/Mount (Polysciences, 18606) using a microscope slide, making sure that the ventral side was toward the coverslip. Embryos were imaged through the ventral side on a Nikon A1-R scanning confocal microscope. The Measurement Points feature of Imaris was used to accurately measure cilia length, even if the cilia pointed in the z direction, by marking points along the cilia.
Code availability. The differential equations corresponding to the mathematical model were solved numerically, using the 'ode15s' subroutine in MATLAB.
Data availability. Fly and zebrafish strains and reagents are available upon request.
